Clinical Trial Update: Z1 Hip System: Post-Market Clinical Follow Up Study

View source ↗

Summary

Post-market clinical follow-up study (PMCF) for the Z1 Hip System by Zimmer Biomet, currently recruiting to evaluate outcomes in hip osteoarthritis and femoral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Head
• Fracture of the Femoral Head
• Fracture of the Femoral Neck
• Osteoarthritis of the Hip

Drugs mentioned

• Z1 Hip System

Snippet

Sponsor: Zimmer Biomet | Conditions: Hip Osteoarthritis, Acute Traumatic Fracture of the Femoral Head or Neck | Status: RECRUITING